Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Gains from Investment Securities (2018 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Gains from Investment Securities for 9 consecutive years, with $66000.0 as the latest value for Q1 2026.

  • For Q1 2026, Gains from Investment Securities fell 99.11% year-over-year to $66000.0; the TTM value through Mar 2026 reached $13.4 million, up 79.21%, while the annual FY2025 figure was $9.8 million, 12.05% up from the prior year.
  • Gains from Investment Securities hit $66000.0 in Q1 2026 for Bicycle Therapeutics, down from $13.3 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $13.3 million in Q4 2025 and bottomed at -$2.1 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is $2.4 million, with a median of $607300.0 recorded in 2025.
  • Year-over-year, Gains from Investment Securities tumbled 14671.43% in 2022 and then soared 16811.43% in 2023.
  • Bicycle Therapeutics' Gains from Investment Securities stood at -$2.1 million in 2022, then surged by 256.38% to $3.2 million in 2023, then crashed by 80.97% to $615496.0 in 2024, then skyrocketed by 2058.91% to $13.3 million in 2025, then tumbled by 99.5% to $66000.0 in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $66000.0, $13.3 million, and $607300.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.